| 1 |
Maron BJ. Clinical course and management of hypertrophic cardiomyopathy [J]. N Engl J Med, 2018, 379(20): 1977.
|
| 2 |
Brough J, Jain M, Jerves T, et al. Genetic screening for hypertrophic cardiomyopathy in large, asymptomatic military cohorts [J]. Am J Med Genet C Semin Med Genet, 2020, 184(1): 124-128.
|
| 3 |
Makavos G, Κairis C, Tselegkidi ME, et al. Hypertrophic cardiomyopathy: an updated review on diagnosis, prognosis, and treatment [J]. Heart Fail Rev, 2019, 24(4): 439-459.
|
| 4 |
Huang G, Fadl SA, Sukhotski S, et al. Apical variant hypertrophic cardiomyopathy "multimodality imaging evaluation" [J]. Int J Cardiovasc Imaging, 2020, 36(3): 553-561.
|
| 5 |
Rowin EJ, Maron BJ, Haas TS, et al. Hypertrophic cardiomyopathy with left ventricular apical aneurysm: Implications for risk stratification and management [J]. J Am Coll Cardiol, 2017, 69(7): 761-773.
|
| 6 |
To AC, Dhillon A, Desai MY. Cardiac magnetic resonance in hypertrophic cardiomyopathy [J]. JACC Cardiovasc Imaging, 2011, 4(10): 1123-1137.
|
| 7 |
中华医学会超声医学分会超声心动图学组. 中国心血管超声造影检查专家共识 [J]. 中华超声影像学杂志, 2016, 25(4): 277-293.
|
| 8 |
Senior R, Becher H, Monaghan M. Clinical practice of contrast echocardiography: recommendation by the European Association of Cardiovascular Imaging (EACVI) 2017 [J]. Eur Heart J Cardiovasc Imaging, 2017, 18(11): 1205-1205af.
|
| 9 |
Rodriguez-Mañero M, Azcárate-Agüero P, Kreidieh B, et al. Quantitative assessment of left ventricular size and function in cardiac transplant recipients: Side-by-side comparison of real time two-dimensional echocardiography, contrast-enhanced two-dimensional echocardiography, three-dimensional echocardiography, and contrast-enhanced three-dimensional echocardiography as compared to magnetic resonance imaging [J]. Echocardiography, 2019, 36(2): 306-311.
|
| 10 |
Xia H, Gan L, Jiang Y, et al. Use of transesophageal echocardiography and contrast echocardiography in the evaluation of cardiac masses [J]. Int J Cardiol, 2017, 236: 466-472.
|
| 11 |
Maddali MM, Arora NR, Kandachar PS, et al. Intraoperative contrast echocardiography: A valuable diagnostic tool [J]. J Cardiothorac Vasc Anesth, 2018, 32(6): e1-e2.
|
| 12 |
Toulemonde MEG, Corbett R, Papadopoulou V, et al. High frame-rate contrast echocardiography: In-Human demonstration [J]. JACC Cardiovasc Imaging, 2018, 11(6): 923-924.
|
| 13 |
Gurunathan S, Karogiannis N, Senior R. Imaging the heart failure patient-need for accurate measurements of left ventricular volumes and ejection fraction: the role of three-dimensional and contrast echocardiography [J]. Curr Opin Cardiol, 2016, 31(5): 459-468.
|
| 14 |
Karagodin I, Genovese D, Kruse E, et al. Contrast-enhanced echocardiographic measurement of longitudinal strain: accuracy and its relationship with image quality [J]. Int J Cardiovasc Imaging, 2020, 36(3): 431-439.
|
| 15 |
Alherbish A, Becher H, Alemayehu W, et al. Impact of contrast echocardiography on accurate discrimination of specific degree of left ventricular systolic dysfunction and comparison with cardiac magnetic resonance imaging [J]. Echocardiography, 2018, 35(11): 1746-1754.
|
| 16 |
Hoffmann R, von BS, Barletta G, et al. Comparison of two- and three-dimensional unenhanced and contrast-enhanced echocardiographies versus cineventriculography versus cardiac magnetic resonance for determination of left ventricular function [J]. Am J Cardiol, 2014, 113(2): 395-401.
|
| 17 |
中华医学会心血管病学分会中国成人肥厚型心肌病诊断与治疗指南编写组, 中华心血管病杂志编辑委员会. 中国成人肥厚型心肌病诊断与治疗指南 [J]. 中华心血管病杂志, 2017, 45(12): 1015-1032.
|
| 18 |
Keramida K, Lazaros G, Nihoyannopoulos P. Right ventricular involvement in hypertrophic cardiomyopathy: Patterns and implications [J]. Hellenic J Cardiol, 2018, pii: S1109-9666(18)30373-7.
|
| 19 |
Guo X, Fan C, Tian L, et al. The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy [J]. PLoS One, 2017, 12(3): e0174118.
|
| 20 |
Kolokotronis K, Kühnisch J, Klopocki E, et al. Biallelic mutation in MYH7 and MYBPC3 leads to severe cardiomyopathy with left ventricular noncompaction phenotype [J]. Hum Mutat, 2019, 40(8): 1101-1114.
|
| 21 |
杨凯, 赵世华, 陆敏杰, 等. 心尖肥厚型心肌病合并左心室心尖部室壁瘤的临床及心脏磁共振特征分析 [J]. 中华心血管病杂志, 2019, 47(7): 534-538.
|
| 22 |
Koo BK, Choi D, Ha JW, et al. Isolated noncompaction of the ventricular myocardium: contrast echocardiographic findings and review of the literature [J]. Echocardiography, 2002, 19(2): 153-156.
|
| 23 |
Wang C, Deng YB, Zhu Y, et al. Evaluation of subtle myocardial noncompaction by contrast echocardiography in patients with hypertrophic cardiomyopathy and its relationship with regional ventricular systolic dysfunction [J]. J Ultrasound Med, 2012, 31(10): 1551-1557.
|
| 24 |
Maron MS, Hauser TH, Dubrow E, et al. Right ventricular involvement in hypertrophic cardiomyopathy [J]. Am J Cardiol, 2007, 100(8): 1293-1298.
|
| 25 |
Mozaffarian D, Caldwell JH. Right ventricular involvement in hypertrophic cardiomyopathy: a case report and literature review [J]. Clin Cardiol, 2001, 24(1): 2-8.
|
| 26 |
Comella A, Magnacca M, Gistri R, et al. Right ventricular involvement in hypertrophic cardiomyopathy. A case report and brief review of the literature [J]. Ital Heart J Suppl, 2004, 5(2): 154-159.
|
| 27 |
Li M, Zhang L, Xie M, et al. Isolated right ventricular hypertrophic obstructive cardiomyopathy [J]. Ann Thorac Surg, 2019, 107(1): e23-e25.
|
| 28 |
Karogiannis N, Senior R. Contrast echocardiography for detection of myocardial perfusion abnormalities: A clinical perspective [J]. Herz, 2017, 42(3): 287-294.
|
| 29 |
吴爵非, 彭冠华, 张建琴, 等. 左心室和心肌声学造影的仪器设置与方法学 [J/CD]. 中华医学超声杂志(电子版), 2019, 16(10): 727-730.
|
| 30 |
Camici PG, Tschöpe C, Di Carli MF, et al. Coronary microvascular dysfunction in hypertrophy and heart failure [J]. Cardiovasc Res, 2020, 116(4): 806-816.
|
| 31 |
Marszalek RJ, John Solaro R, Wolska BM. Coronary arterial vasculature in the pathophysiology of hypertrophic cardiomyopathy [J]. Pflugers Arch, 2019, 471(5): 769-780.
|
| 32 |
Zheng XZ, Shi YY, Chen KQ, et al. Evaluation of regional myocardial perfusion in methamphetamine abusers using real-time myocardial contrast echocardiography [J]. Med Ultrason, 2019, 21(1): 56-61.
|
| 33 |
王婷, 邓又斌, 朱英, 等. 心肌超声造影评价肥厚型心肌病患者局部心肌收缩功能与灌注的关系 [J/CD]. 中华医学超声杂志(电子版), 2011, 8(10): 2104-2110.
|
| 34 |
Moon J, Cho IJ, Shim CY, et al. Abnormal myocardial capillary density in apical hypertrophic cardiomyopathy can be assessed by myocardial contrast echocardiography [J]. Circ J, 2010, 74(10): 2166-2172.
|
| 35 |
栾姝蓉, 李治安, 何怡华, 等. 心肌声学造影超声心动图在肥厚性梗阻型心肌病化学消融术中的作用 [J]. 中华超声影像学杂志, 2002, 11(12): 709-712.
|
| 36 |
Arias EA, Peña-Duque MA, Martínez-Ríos MA. Bubble Contrast Echocardiography for Alcohol Septal Ablation [J]. Rev Esp Cardiol (Engl Ed), 2019, 72(5): 416.
|
| 37 |
Moya MJL, Salido TL, Mestre BJL, et al. Three-dimensional contrast echocardiography-guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy [J]. Eur Heart J Cardiovasc Imaging, 2014, 15(2): 226.
|
| 38 |
Moya MJL, Salido TL, Mestre BJL, et al. Alcohol septal ablation in hypertrophic cardiomyopathy. 3D contrast echocardiography allows localization and quantification of the extension of intraprocedural vascular recruitment [J]. Int J Cardiol, 2014, 174(3): 761-762.
|
| 39 |
Labombarda F, Pellissier A, Saloux É. Fibrosis suggested by 3D contrast-enhanced echocardiography in hypertrophic cardiomyopathy [J]. Arch Cardiovasc Dis, 2011, 104(12): 680-681.
|